Idiopathic Pulmonary Fibrosis Treatment Market Strengthens with Innovative Therapies
Idiopathic Pulmonary Fibrosis (IPF) is a chronic, progressive lung disease characterized by scarring (fibrosis) of lung tissue, which leads to a gradual decline in lung function. The disease primarily affects adults over 50 years of age and has a poor prognosis, with limited treatment options available. As awareness grows and research progresses, the Idiopathic Pulmonary Fibrosis...
0 التعليقات
0 المشاركات
99 مشاهدة